{"webUser":null,"request_id":"3c179717de7898b88b19957c12efc822"}
{"flashNotices":[],"request_id":"3c179717de7898b88b19957c12efc822"}

Applied Clinical Trials / ACT Brief: AI Architecture and Model Ownership Due Diligence, FDA Framework for Generative AI Medical Devices, and Heidi Overton Nominated for FDA Commissioner

View our embed guidelines

Sorry, your browser isn't supported.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.